Davidson Matt 13D/13G Filings for Verrica Pharmaceuticals Inc. (VRCA)

Davidson Matt 13D and 13G filings for Verrica Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-01-27
11:04 am
Sale
2021-12-31 13G Verrica Pharmaceuticals Inc.
VRCA
Davidson Matt 560,731
2.040%
-884,272decrease
(-61.20%)
Filing
2021-01-25
5:13 pm
Sale
2020-12-31 13G Verrica Pharmaceuticals Inc.
VRCA
Davidson Matt 1,445,003
5.600%
-1,028,157decrease
(-41.57%)
Filing